The Food and Drug Administration has issued a call for information about biomarkers in development. Myotonic has submitted a summary of the scientific workshop that we held last fall at the 2014 Myotonic Annual Conference, but we encourage investigators in the myotonic dystrophy field to consider responding directly to the FDA with more detail.

The deadline for the FDA request is May 14, 2015. You can find more information here. If you do respond to the FDA RFI, please email us and let us know.